Fecal immunochemical testing best and most cost-effective method for screening for colorectal cancer

	Tweet

Annual screening by fecal immunochemical testing - a test that detects blood in the stool, has high sensitivity and specificity, and might improve participation rates through increased patient acceptability - reduces the risk of colorectal cancer and colorectal cancer related deaths, and reduces healthcare costs in comparison to all other screening strategies and to no screening. These are the conclusions of a complete economic evaluation performed by Braden Manns and colleagues from the University of Calgary, Alberta, Canada, and published in this week’s PLoS Medicine.

Clinical guidelines recommends screening for colorectal cancer in average risk individuals from 50 years old, yet some countries, such as the UK, do not currently have population-based colorectal cancer screening. Also, many countries with colorectal cancer screening programs do not offer a choice of screening method. In order to inform health policy decision making, the authors used an incremental cost utility analysis, a sophisticated modelling technique, and two hypothetical patient cohorts (individuals with an “average risk”, ie no family history of colorectal cancer, aged 50-64 and 65-75) to compare different colorectal cancer screening methods. In their analysis, the authors considered all costs, such as treatment costs, and non-medical costs (such as costs of travelling to the screening centre), associated with each colorectal cancer screening method. The modelling was based on assumptions concordant with a North American context.

The authors found that annual fecal immunochemical testing was more effective and less costly compared to all strategies (including no screening). Using this screening modality, among the lifetimes of 100,000 average-risk patients, the number of deaths from colorectal cancer was reduced from 1393 to 457. Even after the authors accounted for many different scenarios, screening for colorectal cancer with fecal immunochemical testing remained the most cost effective screening option.

The authors conclude: “Health policy decision makers should consider prioritizing funding for colorectal cancer screening using fecal immunochemical testing.”

###

Funding: This project was supported by the Canadian Agency for Drugs and Technologies in Health and Alberta Innovates - Health Solutions. BJM and RJH are supported by Alberta Innovates - Health Scholar Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Competing Interests: The authors have declared that no competing interests exist.

Citation: Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ (2010) Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation. PLoS Med 7(11): e1000370. doi:10.1371/journal.pmed.1000370

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000370

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-07-11-manns.pdf

CONTACT:

Braden Manns
University of Calgary
Medicine
1403 29th Street NW
CALGARY, AB T2N T29
Canada
403-944-2595
403-944-2876 (fax)

###

Contact: Katie Hickling

44-122-344-2815
Public Library of Science

RELATED STORIES:
Colorectal cancer survival advantage in MUTYH-associated polyposis   Genetic Testing May Be Valuable in Treating Colorectal Cancer   Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death   Consistent exercise associated with lower risk of colon cancer death   7 Things You Should Know About Colon Cancer   City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO   Surgery Complications Linked to Chemotherapy Delay   Genetic ID of Marker in Lymph Nodes May be Linked to Colorectal Cancer Recurrence Risk   Common Genetic Risk Factor for Colorectal and Prostate Cancer Identified   Anesthesiologist Treatment Eases Patient Anxiety for Endoscopic Screening Procedures   Following lifestyle tips could prevent almost a quarter of bowel cancer cases   Morbidly obese patients face high risk for complications after colectomy   New bowel cancer evidence calls for routine DNA repair test   Colonoscopy Prevents Deaths From Colon Cancer   People with HIV not being tested for colon cancer   Use of Chemotherapy After Surgery for Colon Cancer Has Risen   Healthy life could prevent 23 percent of colon cancers   Colon cancer test may not require laxatives: study   Shifting a Paradigm: a Molecular Approach to Staging Colorectal Cancer   Fish tied to lower colon cancer risk: study   Facts About Colorectal Cancer   New App Available in the Fight Against Colon Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]